FDA clears Rex Medical's thrombectomy system

January 17, 2013 by MassDevice staff

Rex Medical lands FDA clearance for its Cleaner15 thrombectomy device, marketing its FDA cleared insulin pump.

Rex Medical won FDA clearance for its Cleaner15 Rotational Thrombectomy System, a device designed to clear occluded blood vessels and stents. 

The Conshohocken, PA.-based medical device company inked a deal with Argon Medical Devices for marketing and distributing its Cleaner and Cleaner15 technologies in the U.S., the European Union, Latin America, Canada and select Asia-Pacific geographies, according to a press release.

Sign up to get our free newsletters delivered right to your inbox.

"We are pleased to receive FDA clearance for our Cleaner15 technology," president Lindsay Carter said in prepared remarks. "This line extension will augment our commercially available Cleaner portfolio and provide an immediate benefit to the significant global patient population undergoing percutaneous thrombectomy treatment."